Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4

被引:31
|
作者
Li, Yan [1 ,3 ]
Liu, Shuang [1 ,3 ]
Ng, Elizabeth Yihui [1 ,3 ]
Li, Rong [1 ]
Poulsen, Anders [1 ]
Hill, Jeffrey [1 ]
Pobbati, Ajaybabu V. [2 ]
Hung, Alvin W. [1 ]
Hong, Wanjin [2 ]
Keller, Thomas H. [1 ]
Kang, CongBao [1 ]
机构
[1] ASTAR, Ctr Expt Therapeut, 31 Biopolis Way,3-01, Singapore 138669, Singapore
[2] ASTAR, Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, 61 Biopolis Dr, Singapore 138673, Singapore
[3] Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England
关键词
PROTEIN-PROTEIN INTERACTION; HIPPO PATHWAY; NMR-SPECTROSCOPY; GROWTH-CONTROL; CANCER; COMPLEXES; SUBUNIT; COACTIVATORS; ANTAGONISTS; ASSIGNMENT;
D O I
10.1042/BCJ20180225
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The oncoprotein YAP (Yes-associated protein) requires the TEAD family of transcription factors for the up-regulation of genes important for cell proliferation. Disrupting YAP-TEAD interaction is an attractive strategy for cancer therapy. Targeting TEADs using small molecules that either bind to the YAP-binding pocket or the palmitate-binding pocket is proposed to disrupt the YAP-TEAD interaction. There is a need for methodologies to facilitate robust and reliable identification of compounds that occupy either YAP-binding pocket or palmitate-binding pocket. Here, using NMR spectroscopy, we validated compounds that bind to these pockets and also identify the residues in mouse TEAD4 (mTEAD4) that interact with these compounds. Flufenamic acid (FA) was used as a positive control for validation of palmitate-binding pocket-occupying compounds by NMR. Furthermore, we identify a hit from a fragment screen and show that it occupies a site close to YAP-binding pocket on the TEAD surface. Our results also indicate that purified mTEAD4 can catalyze autopalmitoylation. NMR studies on mTEAD4 revealed that exchanges exist in TEAD as NMR signal broadening was observed for residues close to the palmitoylation site. Mutating the palmitoylated cysteine (C360S mutant) abolished palmitoylation, while no significant changes in the NMR spectrum were observed for the mutant which still binds to YAP. We also show that FA inhibits TEAD autopalmitoylation. Our studies highlight the utility of NMR spectroscopy in identifying small molecules that bind to TEAD pockets and reinforce the notion that both palmitate-binding pocket and YAP-binding pocket are targetable.
引用
收藏
页码:2043 / 2055
页数:13
相关论文
共 50 条
  • [31] A revisited version of the apo structure of the ligand-binding domain of the human nuclear receptor retinoic X receptor α
    Eberhardt, Jerome
    McEwen, Alastair G.
    Bourguet, William
    Moras, Dino
    Dejaegere, Annick
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2019, 75 : 98 - 104
  • [32] Solution Structure of the PAS Domain of a Thermophilic YybT Protein Homolog Reveals a Potential Ligand-binding Site
    Tan, Edward
    Rao, Feng
    Pasunooti, Swathi
    Thi Huong Pham
    Soehano, Ishin
    Turner, Mark S.
    Liew, Chong Wai
    Lescar, Julien
    Pervushin, Konstantin
    Liang, Zhao-Xun
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (17) : 11949 - 11959
  • [33] Crosslinking the ligand-binding domain dimer interface locks kainate receptors out of the main open state
    Daniels, Bryan A.
    Andrews, Elizabeth D.
    Aurousseau, Mark R. P.
    Accardi, Michael V.
    Bowie, Derek
    JOURNAL OF PHYSIOLOGY-LONDON, 2013, 591 (16): : 3873 - 3885
  • [34] Upregulation of CDC25B by transcription factor TEAD4 drives invasion and inhibits cisplatin sensitivity through cell adhesion in stomach adenocarcinoma
    Zhang, Tao
    Chen, Lijian
    Li, Shuang
    Shen, Chao
    ANTI-CANCER DRUGS, 2024, 35 (10) : 922 - 931
  • [35] Rational ligand-based virtual screening and structure activity relationship studies in the ligand-binding domain of the glucocorticoid receptor-α
    Onnis, Valeria
    Kinsella, Gemma K.
    Carta, Giorgio
    Fayne, Darren
    Lloyd, David G.
    FUTURE MEDICINAL CHEMISTRY, 2009, 1 (03) : 483 - 499
  • [36] Dynamics of Cleft Closure of the GluA2 Ligand-binding Domain in the Presence of Full and Partial Agonists Revealed by Hydrogen-Deuterium Exchange
    Ahmed, Ahmed H.
    Ptak, Christopher P.
    Fenwick, Michael K.
    Hsieh, Ching-Lin
    Weiland, Gregory A.
    Oswald, Robert E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (38) : 27658 - 27666
  • [37] Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
    Arao, Yukitomo
    Korach, Kenneth S.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (142):
  • [38] Design and expression of human α7 nicotinic acetylcholine receptor extracellular domain mutants with enhanced solubility and ligand-binding properties
    Zouridakis, Marios
    Zisimopoulou, Paraskevi
    Eliopoulos, Elias
    Poulas, Konstantinos
    Tzartos, Socrates J.
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2009, 1794 (02): : 355 - 366
  • [39] Mapping of the ligand-binding site on the b′ domain of human PDI: interaction with peptide ligands and the x-linker region
    Byrne, Lee J.
    Sidhu, Ateesh
    Wallis, A. Katrine
    Ruddock, Lloyd W.
    Freedman, Robert B.
    Howard, Mark J.
    Williamson, Richard A.
    BIOCHEMICAL JOURNAL, 2009, 423 : 209 - 217
  • [40] Advances in Vitamin D Receptor Function and Evolution Based on the 3D Structure of the Lamprey Ligand-Binding Domain
    Sigueiro, Rita
    Bianchetti, Laurent
    Peluso-Iltis, Carole
    Chalhoub, Sandra
    Dejaegere, Annick
    Osz, Judit
    Rochel, Natacha
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (07) : 5821 - 5829